Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126478941 | 12647894 | 1 | I | 201606 | 20160802 | 20160812 | 20160812 | EXP | FR-PFIZER INC-2016371561 | PFIZER | 10.00 | YR | M | Y | 45.00000 | KG | 20160812 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126478941 | 12647894 | 1 | PS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | 2 MG, SINGLE | Y | 71484 | 2 | MG | SOLUTION FOR INJECTION | ||||||
| 126478941 | 12647894 | 2 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | UNK | Y | 71484 | SOLUTION FOR INJECTION | |||||||||
| 126478941 | 12647894 | 3 | SS | Aracytine | CYTARABINE | 1 | Intrathecal | 30 MG, SINGLE | Y | 71868 | 30 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | ||||||
| 126478941 | 12647894 | 4 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 32.5 MG, SINGLE | Y | 11719 | 32.5 | MG | |||||||
| 126478941 | 12647894 | 5 | SS | PURINETHOL | MERCAPTOPURINE | 1 | Oral | 50 MG DAILY EXCEPT 100 MG DAILY ON SATURDAY AND SUNDAY | Y | 0 | TABLET | ||||||||
| 126478941 | 12647894 | 6 | SS | PURINETHOL | MERCAPTOPURINE | 1 | UNK | Y | 0 | TABLET | |||||||||
| 126478941 | 12647894 | 7 | SS | METHOTREXATE (METHOTREXATE SODIUM) | METHOTREXATE SODIUM | 1 | Intravenous (not otherwise specified) | 6850 MG, SINGLE | Y | 0 | 6850 | MG | SOLUTION FOR INJECTION | ||||||
| 126478941 | 12647894 | 8 | SS | METHOTREXATE (METHOTREXATE SODIUM) | METHOTREXATE SODIUM | 1 | Intrathecal | 15 MG, SINGLE | Y | 0 | 15 | MG | SOLUTION FOR INJECTION | ||||||
| 126478941 | 12647894 | 9 | C | CORTANCYL | PREDNISONE | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 126478941 | 12647894 | 10 | C | PENTACARINAT | PENTAMIDINE ISETHIONATE | 1 | UNK | 0 | |||||||||||
| 126478941 | 12647894 | 11 | C | FOLINIC ACID | LEUCOVORIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126478941 | 12647894 | 1 | T-cell type acute leukaemia |
| 126478941 | 12647894 | 3 | T-cell type acute leukaemia |
| 126478941 | 12647894 | 4 | T-cell type acute leukaemia |
| 126478941 | 12647894 | 5 | T-cell type acute leukaemia |
| 126478941 | 12647894 | 7 | T-cell type acute leukaemia |
| 126478941 | 12647894 | 9 | T-cell type acute leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126478941 | 12647894 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126478941 | 12647894 | Febrile bone marrow aplasia | |
| 126478941 | 12647894 | Stomatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126478941 | 12647894 | 1 | 20160621 | 20160621 | 0 | |
| 126478941 | 12647894 | 2 | 20160707 | 0 | ||
| 126478941 | 12647894 | 3 | 20160622 | 20160622 | 0 | |
| 126478941 | 12647894 | 4 | 20160628 | 20160628 | 0 | |
| 126478941 | 12647894 | 5 | 20160621 | 20160628 | 0 | |
| 126478941 | 12647894 | 6 | 20160707 | 0 | ||
| 126478941 | 12647894 | 7 | 20160621 | 20160621 | 0 | |
| 126478941 | 12647894 | 8 | 20160622 | 20160622 | 0 | |
| 126478941 | 12647894 | 9 | 20160621 | 20160621 | 0 | |
| 126478941 | 12647894 | 11 | 20160623 | 20160623 | 0 |